EUVIMEDEUVIMED entdecken
Crossref

Mendelian randomization and single-cell transcriptomics prioritize CD7 and LAPTM5 in primary Sjögren’s disease: an integrative multi-omics analysis

Xiaodan Liu, Yousheng Jiang, Jing Zang, Hung Hsiang Hao, Xiao Wang, Zhihui Zhang

Clinical Rheumatology · 2026-11 · 45 (11) · 6831-6849

DOI: 10.1007/s10067-026-08438-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 30.09.2026. Verfasst von Xiaodan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Peking University Third Hospital, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Membrane Proteins. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Peking University Medicine Seed Fund for Interdisciplinary Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Primary Sjögren's disease (pSD) is a chronic autoimmune condition marked by exocrine gland dysfunction. Emerging evidence indicates that lactylation modification may contribute to the pathogenesis of autoimmune diseases; however, its role in pSD has yet to be investigated. METHODS: We conducted an integrated analysis combining single-cell RNA sequencing data (GSE157278), bulk transcriptome data (GSE51092), and whole-blood eQTL data with Mendelian randomization (MR) and colocalization analysis. Expanded single-cell quality-control analyses were performed, and lactylation-related gene-set scores (332 literature entries representing 330 unique genes) were quantified using five algorithms as an exploratory analysis, together with method-sensitivity and library-complexity-corrected analyses. RT-qPCR in peripheral blood mononuclear cells (PBMCs) was performed as an explohhratory analysis. RESULTS: MR identified ten nominal associations between gene expression and an electronic health record-based sicca syndrome phenotype (PheCode 709.2), including CD7 (OR = 0.50, P = 0.0033) and LAPTM5 (OR = 1.29, P = 0.0088); colocalization analysis supported shared underlying variants at both loci, prioritizing CD7 and LAPTM5 as candidate genes; reverse MR was negative. In an additional disease-state expression analysis of the whole-blood GSE51092 cohort (190 patients, 32 controls), CD7 expression was significantly lower in patients (fold-change 0.74, q = 2.8 × 10-4), directionally concordant with its genetically predicted protective effect, as was a 12-gene megakaryocyte/platelet signature (standardized mean difference - 0.31, 95% CI - 0.56 to - 0.06; Welch q = 0.045). A megakaryocyte/platelet-like population was present in all ten single-cell donors and was supported by marker panels and differential-expression analysis. Exploratory lactylation-related gene-set scores were method-dependent and not robustly cell-type-specific after library-complexity correction; at the sample level, scores were nominally higher in patients' CD14 + monocytes (P = 0.016, q = 0.095) and NK cells (P = 0.032, q = 0.095), and within the megakaryocyte/platelet-like population, the score-associated transcriptional variation of CD7 and LAPTM5 was the largest among the six cell types. RT-qPCR in PBMCs (10 patients, 10 controls) showed directionally upward but statistically non-significant trends for LAPTM5 (median fold-change 2.9) and CD7 (median fold-change 1.7). CONCLUSIONS: CD7 and LAPTM5 emerged as candidates at the intersection of pSD transcriptomic findings and genetic associations with a broader sicca/Sjögren spectrum phenotype, with distinct immunological pathway profiles, and whole-blood disease-state data corroborate the direction of the CD7 association. Megakaryocyte/platelet-lineage cells warrant further investigation in pSD. Lactylation-related transcriptomic scores are surrogates that require direct experimental validation, and studies in disease-relevant tissues are needed. Key Points • Characterization of a megakaryocyte/platelet-like population in peripheral blood: We characterized this population in pSD and control PBMCs using expanded quality control, marker panels, and differential-expression analysis, in line with prior flow-cytometric evidence of circulating megakaryocyte expansion in systemic autoimmune diseases. • Genetically prioritized candidate genes: By integrating Mendelian randomization with colocalization analysis and single-cell transcriptomics, we identified LAPTM5 and CD7 as candidate genes supported by convergent pSD transcriptomic findings and nominal genetic associations with a broader sicca phenotype. • Elucidation of functional pathways: We delineated the distinct immunological pathways linked to these genes, with LAPTM5 linked to Notch signaling and complement cascades, while CD7 is involved in antigen presentation and NK cell cytotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeMembrane ProteinsHumansTranscriptomeSingle-Cell AnalysisLeukocytes, MononuclearSingle-Cell Gene Expression AnalysisQuantitative Trait Loci

Stichwörter der Autor:innen

CD7LAPTM5Lactylation-related genesMegakaryocyteMendelian randomizationPrimary Sjögren's diseaseSingle-cell sequencing

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Department of Stomatology, Peking University Third Hospital, Beijing, People's Republic of China.
  • Department of Ocular Diseases, Beijing Aier Eye Hospital, Beijing, People's Republic of China.
  • Department of Stomatology, Peking University Third Hospital, Beijing, People's Republic of China. wangxiao@bjmu.edu.cn.
  • Department of Stomatology, Peking University Third Hospital, Beijing, People's Republic of China. wisdomzhangzhihui@163.com.

Förderung

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Peking University Medicine Seed Fund for Interdisciplinary Research
  • International Science and Technology Cooperation Programme
  • Innovation& Transfer Fund of Peking University Third Hospital

Zitieren

APA

Liu, X., Jiang, Y., Zang, J., Hao, H. H., Wang, X., & Zhang, Z. (2026). Mendelian randomization and single-cell transcriptomics prioritize CD7 and LAPTM5 in primary Sjögren’s disease: an integrative multi-omics analysis. Clinical Rheumatology, 45(11), 6831-6849. https://doi.org/10.1007/s10067-026-08438-8

Vancouver

Liu X, Jiang Y, Zang J, Hao HH, Wang X, Zhang Z. Mendelian randomization and single-cell transcriptomics prioritize CD7 and LAPTM5 in primary Sjögren’s disease: an integrative multi-omics analysis. Clinical Rheumatology. 2026;45(11):6831-6849. doi:10.1007/s10067-026-08438-8

BibTeX
@article{Liu2026,
  author = {Liu, Xiaodan and Jiang, Yousheng and Zang, Jing and Hao, Hung Hsiang and Wang, Xiao and Zhang, Zhihui},
  title = {Mendelian randomization and single-cell transcriptomics prioritize CD7 and LAPTM5 in primary Sjögren’s disease: an integrative multi-omics analysis},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {6831--6849},
  doi = {10.1007/s10067-026-08438-8}
}
Kostenlos starten →